{
    "key": "2018-0005",
    "name": "Zoster: Dose #2 (Shingrix) administered at 4 weeks - 1 days after dose #1",
    "cdcTestId": "2018-0005",
    "changedInVersion": "4.0",
    "dateAdded": "2018-03-27T20:00:00",
    "dateUpdated": "2020-05-29T08:33:46.927",
    "evaluation": {
        "administeredDoses": [
            {
                "cvx": "187",
                "dateAdministered": "2020-07-16T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "zoster recombinant"
            },
            {
                "cvx": "187",
                "dateAdministered": "2020-08-12T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "zoster recombinant"
            }
        ],
        "seriesStatus": "Complete"
    },
    "evaluationTestType": "Interval: At Absolute Minimum ",
    "forecast": {
        "earliestDate": "0001-01-01T00:00:00",
        "forecastNum": "",
        "pastDueDate": "0001-01-01T00:00:00",
        "recommendedDate": "0001-01-01T00:00:00"
    },
    "forecastTestType": "Not recommended: series complete",
    "generalDescription": "This test case describes when an adult patient is administered the second dose of Shingrix vaccine at 4 weeks - 1 day, that the dose is considered to be valid.",
    "patient": {
        "dob": "1970-07-16T00:00:00",
        "gender": "M",
        "medHistoryCode": "",
        "medHistoryCodeSys": "",
        "medHistoryText": "",
        "doses": [
            {
                "cvx": "187",
                "dateAdministered": "2020-07-16T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "zoster recombinant"
            },
            {
                "cvx": "187",
                "dateAdministered": "2020-08-12T00:00:00",
                "evaluationReason": "",
                "evaluationStatus": "Valid",
                "mvx": "",
                "vaccineName": "zoster recombinant"
            }
        ]
    },
    "reasonForChange": "V4.0 Per SME Guidance, the four day grace period can be used. Second dose has been changed to \"valid\".\nV3.5: Previous version was calculating the forecast from the first dose. This has been corrected to be from the previous dose (invalid dose #2).",
    "testcaseName": "Zoster: Dose #2 (Shingrix) administered at 4 weeks - 1 days after dose #1",
    "vaccineGroup": "ZOSTER"
}